STRIDES PHARMA SCIENCE LIMITED — Major Shareholding Notification 2020

Sep 28, 2020

PRONOMZ VENTURES LLP

Regd. Office: Plot No. 30, 'Galaxy', 1st Main Road, J. P. Nagar Third Phase, Bengaluru - 560 078, Karnataka. India Tel.: +91 80 4657 0300 | Fax: +91 80 4657 0400 | E-mail: info@agnus.in | www.agnus.in | LLPIN: AAA-3757

28 September 2020

Mumbai - 400 001	Bandra (E), Mumbai - 400 051
Dalal Street,	Bandra Kurla Complex,
Phiroze Jeejeebhoy Towers,	Exchange Plaza,
BSE Limited	National Stock Exchange of India Limited
-10

Scrip code: 532531

Scrip code: STAR

Ms. Manjula Ramamurthy Company Secretary & Compliance Officer Strides Pharma Science Ltd 201. Devavrata. Sector 17. Vashi, Navi Mumbai- 400703.

Dear Sir/Madam,

Sub: Disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 - Intimation to Stock Exchanges in respect of acquisition under Regulation $10(1)(a)(ii)$

Further to our intimation dated 19th September 2020 under regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (SAST Regulations), please find enclosed the form as prescribed under Regulation 10(6) of the SEBI SAST Regulations setting out the details of the acquisition of shares of Strides Pharma Science Ltd done inter-se among promoters in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 2011 and there is no change in promoter holding consequent to such transfer.

Kindly take the same on record.

Thanking you, Yours faithfully,

For and on behalf of M/s Pronomz Ventures LLP [Promoter Group Entity of Strides Pharma Science Ltd]

Designated Partner Encl.: A/a

PRONOMZ VENTURES LLP

Regd. Office: Plot No. 30, 'Galaxy', 1st Main Road, J. P. Nagar Third Phase, Bengaluru - 560 078, Karnataka. India Tel.: +91 80 4657 0300 | Fax: +91 80 4657 0400 | E-mail: info@agnus.in | www.agnus.in | LLPIN: AAA-3757

Disclosures under Regulation 10(6) Report to Stock Exchanges in respect of any acquisition made in reliance upon exemption provided for in Regulation 10 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

1.		Name of the Target Company (TC)	Strides Pharma Science Ltd
2.		Name of the acquirer(s)	Pronomz Ventures LLP
3.		Name of the stock exchange whereshares of the TC are listed	BSE Limited ('BSE') and National Stock Exchange of IndiaLimited ('NSE')
4.5.	Detailsof the transactionSale of shares by Sequent Scientific Limited ('Sequent') in Stridesincludingrationale, if any,for the transfer/Pharma Science Ltd through inter-se promoter transfer toacquisition of sharesPronomz Ventures LLPRelevant regulation under which the acquirer
		is exempted from making open offer	Regulation 10(1)(a)(ii) of SEBI (Substantial Acquisition of Sharesand Takeovers) Regulations, 2011
6:	$(5)$ and if so,	Whether disclosure of proposed acquisitionwas required to be made under regulation 10- whether disclosure was made andwhether it was made within the timeline- specified under the regulations.- date of filing with the stock exchange	Yes
7.	Details of acquisition		Disclosures required to bemade underregulation 10(5)		Whether thedisclosures underregulation 10(5)are actually made
	a.	Name of the transferor / seller	Sequent Scientific Limited		Yes
	b.	Date of acquisition	25th September 2020		Yes
	Number of shares/voting rightsc.in respect of the acquisitions	Name of person	No of EquityShares	Yes
		from eachperson mentioned in 7(a) above	Sequent ScientificLimited	3.70%
	d.	Total shares proposed to beacquired / actually acquired as a% of diluted share capital of TC	3.70%Rs. 475 per share		Yes
	e÷	Price at which shares areproposed tobe acquired / actually acquired

PRONOMZ VENTURES LLP

Regd. Office: Plot No. 30, 'Galaxy', 1st Main Road, J. P. Nagar Third Phase, Bengaluru - 560 078, Karnataka. India Tel.: +91 80 4657 0300 | Fax: +91 80 4657 0400 | E-mail: info@agnus.in | www.agnus.in | LLPIN: AAA-3757

8.		Shareholding details	Pre-Transaction		Post-Transaction
			No. of shares	% w.r.t total share	ofNo.	% w.r.t
			held	capital of TC	shares	total
					held	share
						capital
						of TC
	$\overline{A}$	Acquirer(s) and PACs (otherthan sellers)(*)
	(i)	Pronomz Ventures LLP	1,26,65,000	14.13%	1,59,77,500	17.83%
	B	Seller (s)
	(i)	Sequent Scientific Limited	33,12,500	3.70%		0.00%

(*) Shareholding of each entity shall be shown separately and then collectively in a group.

The above disclosure shall be signed by the acquirer mentioning date & place. In case, there is more than one acquirer, the report shall be signed either by all the persons or by a person duly authorized to do so on behalf of all the acquirers.

Signature:

Name: Pudhucode Radhakrishnan Kannan (Designated Partner)

Date: Bengaluru Place: 28 September 2020

Arun Kumar Family Office increase its holding in Strides by 4.37%

Purchases 3.31 million shares from SeQuent and 600,000 shares from Shasun family

The family office of Arun Kumar, founder and non-executive Chairman of Strides Pharma Science Limited("Strides" or "Company") would like to update that it has completed the purchase of 3.31 million shares(3.70% of Total Outstanding Shares) of Strides held by SeQuent Scientific Limited("SeQuent") for an aggregate consideration of ₹1,573 million. The transaction was duly approved by the Shareholders of SeQuent on Sep 19, 2020.

Further, on Sep 11, 2020, the Family Office of Arun Kumar also purchased 600,000 shares(0.67% of the total outstanding shares) of Strides from the Shasun family who are also promoters in the Company.

The information has been shared with the Company and its stakeholders for prudent disclosures.